LinQURE:一种新的AAV基因沉默平台,支持复杂疾病的多转录向
Irena Bočkaj1, Anna Moreno Garcia1, Pablo de Miguel Herraiz1
1Global Research, uniQure biopharma B.V., 1105 BP Amsterdam, the Netherlands.
Molecular therapy. Nucleic acids
|September 18, 2024
概括
再组合腺相关病毒 (rAAV) 基因疗法创新正在推进. 一个新的linQURE平台使用多个microRNAs (miRNAs) 来准致病基因,改善复杂遗传疾病的基因沉默.
科学领域:
- 分子生物学分子生物学
- 基因治疗 基因治疗
- 生物技术是生物技术.
背景情况:
- 再组合腺相关病毒 (rAAV) 提供的基因疗法为许多遗传疾病提供了潜力.
- 使用基于microRNA (miRNA) 的miQURE技术准有毒转录可以减少遗传疾病的进展.
- 复杂的遗传疾病涉及多个基因,需要多个向的治疗策略.
研究的目的:
- 为新型linQURE平台建立一个机制的证明.
- 证明linQURE能够同时表达多个合成miRNA的能力.
- 通过使用linQURE平台,展示致病mRNA标的有效下调.
主要方法:
- 扩展miQURE基因沉默策略,将多个miQURE分子连接成一个单一结构.
- 开发linQURE平台,用于同时表达miRNA.
- 在体外和体内验证linQURE技术的疗效.
主要成果:
- 该linQURE平台成功实现了两个合成miRNAs的同时表达.
- 与单个miRNA方法相比,证明了导致疾病的mRNA标的更有效的下调.
- 验证了该技术在体外和体外的有效性.
结论:
- linQURE平台代表了基因疗法的新进展,使多个向策略成为可能.
- 这项技术扩大了基因治疗的潜力,以解决复杂的多基因征兆.
- linQURE增强了治疗工具箱,用于开发适应性基因疗法,用于各种遗传疾病.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Regulation of Expression at Multiple Steps
875
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
875
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Regulation of Expression Occurs at Multiple Steps
22.5K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.5K


